Family III, set from the shelf on 16 October 2026
Family III8 linesFriday 16 October 2026
Family III Growth & IGF research peptides, by the box
Growth hormone secretagogues, GHRH analogues and IGF-1 variants for endocrine and growth-axis research, supplied as sealed vials of lyophilised powder with batch documentation.
810CpCJC-1295$71.52155IpIpamorelin$42.072510IpIpamorelin$68.72395TsmTesamorelin$151.464010TsmTesamorelin$287.484120TsmTesamorelin$556.74165CndCJC-1295 no DAC$119.214210CndCJC-1295 no DAC$221.58
Fig. 1Growth & IGF on 16 October 2026, one column to a compound with its strengths stacked; hatched tiles are landing by 25 October.
| No. | Tile | LinePer box | Per mg | Status | Add |
|---|---|---|---|---|---|
| 8 | CJC-1295 10mg$71.52 CP10 · 10 mg × 10 vials | $0.715 / mg | A few boxes left | ||
| 15 | Ipamorelin 5mg$42.07 IP5 · 5 mg × 10 vials | $0.841 / mg | A few boxes left | ||
| 25 | Ipamorelin 10mg$68.72 IP10 · 10 mg × 10 vials | $0.687 / mg | A few boxes left | ||
| 39 | Tesamorelin 5mg$151.46 TSM5 · 5 mg × 10 vials | $3.03 / mg | Lands by 25 October | ||
| 40 | Tesamorelin 10mg$287.48 TSM10 · 10 mg × 10 vials | $2.87 / mg | Lands by 25 October | ||
| 41 | Tesamorelin 20mg$556.74 TSM20 · 20 mg × 10 vials | $2.78 / mg | Lands by 25 October | ||
| 16 | CJC-1295 Without DAC 5mg$119.21 CND5 · 5 mg × 10 vials | $2.38 / mg | A few boxes left | ||
| 42 | CJC-1295 Without DAC 10mg$221.58 CND10 · 10 mg × 10 vials | $2.22 / mg | Lands by 25 October |
Notes to the family
- Eight lines across four compounds: 4 on the shelf, 4 landing by 25 October.
- Lowest price per milligram in the family: Ipamorelin 10mg, $0.687 per mg.
- Certificates. Every batch is released at 98.0% or better by RP-HPLC, with its certificate of analysis tied to the batch number on the box. How we test.
- Research use only. Sold for laboratory research. Not for human or veterinary use.